Choose NJ Sponsor Profiles 2

On May 27, 2015

Advancing Innovative Ideas in NJ

New Jersey Health Foundation (NJHF) is a not-for-profit corporation supporting biomedical research, education and healthcare programs in New Jersey through its Grant Programs and its affiliate, Foundation Venture Capital Group (FVCC), which provides pre-seed investments to help biomedical startup companies advance toward commercialization.

FVCG has already invested in 10 companies and is looking to invest in others. Portfolio companies to date:

Actinobac Biomed, developing a therapeutic agent targeting blood cells to treat hematological malignancies, autoimmune/inflammatory diseases and latent infections
Affineti Biologics, advancing therapeutic and diagnostic products in oral biology and dental medicine
CellXplore, developing biomarker-based in vitro diagnostic assays
for cancer
Celvive, working to treat patients with chronic spinal cord injuries using their own adult stem cells
Durin Technologies, developing a diagnostic blood test for Alzheimer’s disease and Parkinson’s disease
GeneAssess, using the FRY gene as a predictive biomarker for breast and other cancers
Longevica Pharmaceuticals (sold)
MentiNova, validating a drug to reduce side effects of L-Dopa
Induced Dyskinesia
NovoPedics, developing an implantable meniscus replacement/regeneration medical device to restore mobility to patients with severe meniscus knee injuries
Snowdon Pharmaceuticals, focused on drug discovery in several major therapeutic areas, providing computational tools to rapidly identify high-value molecules from their library of vendor-available compounds

120 Albany Street, Tower II, Suite 850,
New Brunswick, NJ 08901

908-731-6610

www.njhf.org

www.foundationventure.com

BAC: Helping Business Grow and Flourish

The New Jersey Business Action Center (BAC) is deeply committed to helping businesses grow and flourish in this state. New Jersey’s life sciences sector is a foremost priority. The BAC provides a non-stop proactive customer service approach, providing businesses with a single point of contact. Our team offers companies of all sizes valuable advocacy to help with permitting and regulatory issues, as well as information and access to scores of business assistance and finance programs, both domestic and global.

For companies looking to expand into international markets, the BAC’s Office of International Business Development & Protocol helps companies access free export consulting, identifies buyers and new international markets, provides trade advocacy, assists with finding partners for joint ventures and can assist with site selection services for new investors seeking a corporate presence in the state.

New Jersey’s Biotech community is booming with positive growth. Any way you look at it, New Jersey is at the center of very exciting research development opportunities in the biotechnology industry. The New Jersey Business Action Center is here to offer our expertise to help this vital industry continue to thrive.

225 West State Street, Trenton, NJ 08625

866-534-7789

www.nj.gov/njbusiness

Rutgers University: Open for Business

Established in 1766, Rutgers, The State University of New Jersey, is America’s eighth oldest institution of higher learning and one of the nation’s premier public research universities, educating more than 65,000 students. Rutgers’ flagship, based in New Brunswick, is the only public institution in New Jersey represented in the prestigious Association of American Universities. Rutgers is a member of the Big Ten Conference and its academic counterpart, the Committee on Institutional Cooperation – a consortium of 15 world-class research universities. Rutgers is among the top 30 universities nationally for total R&D funding. The Office of Research and Economic Development provides a central point for industry to access Rutgers through its Corporate Engagement Team and a new website, businessportal.rutgers.edu.

The university’s externally sponsored research grants and contracts in fiscal year 2014 totaled nearly $518 million. Federal funding for Rutgers research was approximately $272 million in FY14. Research expenditures now exceed $746 million annually, which ranks Rutgers among the top 30 universities nationally and #6 in the Big Ten. Also in terms of research funding, Rutgers is ranked #3 nationally in mathematics, #5 in social sciences and #8 in chemistry.

96 Frelinghuysen Road, 7th Floor, Piscataway, NJ 08854

Phone: 848-445-3153

Fax: 732-335-3180

[email protected]

https://businessportal.rutgers.edu

Introducing Taiho Oncology

Taiho Oncology, Inc., a division of Taiho Pharmaceutical Co., Ltd. and Otsuka Holdings Co., Ltd., has built a world class clinical development organization that works to develop innovative cancer treatments and is in the process of building commercial businesses in the USA and Europe.

Backed by a strong corporate financial presence and an expanded global presence in Asia and Europe, the stage is set for Taiho Oncology to emerge as a leading oncology company over the next several years in the United States.

Taiho is focusing on novel technology for cornerstone chemotherapies across a wide range of tumor types, including colorectal cancer and other solid tumors, with a pipeline consisting of both novel antimetabolic agents and selectively targeted agents. Advanced technology, dedicated researchers, and state-of-the-art facilities are helping us to define the way the world treats cancer.

We recognize how our products may touch the lives of cancer patients, caregivers, healthcare professionals and everyone else involved in caring and advocating for these patients. It’s our work; it’s our passion; it’s our legacy.

For more information about Taiho Oncology, please visit: www.taihooncology.com.

202 Carnegie Center, Suite 100

Princeton, NJ 08540

Phone: 609-750-5300

Fax: 609-750-7450

[email protected]